EUVIMEDEUVIMED entdecken
Übersichtsarbeit

NK cells in breast cancer

Andréa Massidda, Santiago Moragon-Terencio, Camille Baudesson de Chanville, Fabrice André, Eric Vivier, Emilie Narni-Mancinelli

Trends in Immunology · 2026-08

DOI: 10.1016/j.it.2026.07.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-08. Verfasst von Andréa Massidda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Université, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'…. Die Arbeit nennt 80 Literaturangaben. Gefördert von: Aix-Marseille Université, Innate Pharma, European Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are effectors of innate antitumor immunity, yet their therapeutic potential in solid tumors remains largely unrealized. Breast cancer exemplifies this paradox: NK cells are present in circulation and detectable within tumors, but their cytotoxic activity is limited. Recent advances in single-cell and spatial profiling reveal that NK-cell failure in breast cancer does not result from simple immune absence but from multilayered constraints imposed by the tumor ecosystem. Soluble mediators, metabolic pressures, stromal architecture, and suppressive immune networks reprogram NK-cell identity and uncouple activation from cytotoxicity. Understanding how these constraints shape NK-cell states reframes breast cancer as a model of innate immune dysfunction and highlights new opportunities to reestablish NK-cell function through immunotherapies.

Autor:innen und Institutionen

  • Aix Marseille Université, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Université Paris-Saclay, UVSQ, Gustave Roussy, Inserm, CESP, 94800 Villejuif, France.
  • Aix Marseille Université, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Immunologie de Marseille-Luminy, Marseille, France; Assistance Publiqu…
  • Aix Marseille Université, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Immunologie de Marseille-Luminy, Marseille, France. Electronic address…

Förderung

  • Aix-Marseille Université
  • Innate Pharma
  • European Research Council
  • Institut National de la Santé et de la Recherche Médicale
  • Centre National de la Recherche Scientifique
  • MSD
  • Institut National Du Cancer
  • Canceropôle PACA

Zitieren

APA

Massidda, A., Moragon-Terencio, S., de Chanville, C. B., André, F., Vivier, E., & Narni-Mancinelli, E. (2026). NK cells in breast cancer. Trends in Immunology. https://doi.org/10.1016/j.it.2026.07.007

Vancouver

Massidda A, Moragon-Terencio S, de Chanville CB, André F, Vivier E, Narni-Mancinelli E. NK cells in breast cancer. Trends in Immunology. 2026. doi:10.1016/j.it.2026.07.007

BibTeX
@article{Massidda2026,
  author = {Massidda, Andréa and Moragon-Terencio, Santiago and de Chanville, Camille Baudesson and André, Fabrice and Vivier, Eric and Narni-Mancinelli, Emilie},
  title = {NK cells in breast cancer},
  journal = {Trends in Immunology},
  year = {2026},
  doi = {10.1016/j.it.2026.07.007}
}
Kostenlos starten →